Cellectar Biosciences - 13 Year Stock Price History | CLRB

Historical daily share price chart and data for Cellectar Biosciences since 2005 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Cellectar Biosciences as of October 19, 2018 is 2.69.
Cellectar Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 8.2309 13.7000 13.7000 2.1900 2.6900 -80.36%
2017 17.2692 12.8000 26.6000 11.2000 13.7000 12.30%
2016 31.0365 73.2000 76.1500 10.5000 12.2000 -83.40%
2015 250.6595 306.0100 355.0000 68.5000 73.5000 -76.21%
2014 552.5469 760.0000 840.0000 198.9500 309.0000 -58.24%
2013 910.9524 1480.0000 1580.0000 600.0000 740.0000 -50.00%
2012 1921.5200 900.0000 4000.0000 860.0000 1480.0000 68.18%
2011 4315.7937 12240.0000 15300.0000 740.0000 880.0000 -90.41%
2010 113632.8571 908820.0000 908820.0000 6120.0000 9180.0000 -98.82%
2009 215997.1429 143820.0000 777240.0000 104040.0000 777240.0000 440.43%
2008 158587.8261 186660.0000 244800.0000 67320.0000 143820.0000 -21.67%
2007 260855.8566 275400.0000 416160.0000 131580.0000 183600.0000 -31.82%
2006 374575.6972 581400.0000 691560.0000 192780.0000 269280.0000 -56.44%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.010B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.867B 19.45
Abbott Laboratories (ABT) United States $118.574B 24.05
Stryker (SYK) United States $63.182B 24.41
Boston Scientific (BSX) United States $50.532B 26.29
Baxter (BAX) United States $37.110B 25.26
Zimmer Biomet Holdings (ZBH) United States $25.314B 16.26
ResMed (RMD) United States $14.694B 29.17
Smith & Nephew SNATS (SNN) United Kingdom $14.608B 0.00
Canopy Growth (CGC) Canada $10.780B 0.00
Perrigo (PRGO) Ireland $9.837B 13.96
Bio-Rad Laboratories (BIO) United States $8.382B 53.82
Hill-Rom Holdings (HRC) United States $5.797B 19.66
Haemonetics (HAE) United States $5.495B 50.15
ICU Medical (ICUI) United States $5.418B 36.71
Insulet (PODD) United States $5.203B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.301B 0.00
Hutchison China MediTech (HCM) China $4.012B 0.00
Agios Pharmaceuticals (AGIO) United States $3.879B 0.00
Neogen (NEOG) United States $3.281B 49.69
NuVasive (NUVA) United States $3.191B 30.27
National Vision Holdings (EYE) United States $3.137B 69.28
Quidel (QDEL) United States $2.525B 51.73
NxStage Medical (NXTM) United States $1.815B 0.00
Phibro Animal Health (PAHC) United States $1.784B 25.40
Cardiovascular Systems (CSII) United States $1.263B 727.80
AtriCure (ATRC) United States $1.071B 0.00
VAREX IMAGING (VREX) United States $0.985B 16.09
Owens & Minor (OMI) United States $0.934B 9.99
OraSure Technologies (OSUR) United States $0.904B 59.08
Cerus (CERS) United States $0.887B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.874B 25.81
PetIQ (PETQ) United States $0.862B 28.18
Surmodics (SRDX) United States $0.842B 101.77
MacroGenics (MGNX) United States $0.792B 0.00
Omeros (OMER) United States $0.770B 0.00
Insys Therapeutics (INSY) United States $0.662B 0.00
Meridian Bioscience (VIVO) United States $0.660B 22.57
LeMaitre Vascular (LMAT) United States $0.542B 26.97
Lantheus Holdings (LNTH) United States $0.517B 16.07
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.445B 0.00
Quanterix (QTRX) United States $0.398B 0.00
Evolus (EOLS) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.323B 0.00
Cytosorbents (CTSO) United States $0.321B 0.00
Surface Oncology (SURF) United States $0.220B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.204B 0.00
Chimerix (CMRX) United States $0.173B 0.00
Fonar (FONR) United States $0.149B 7.32
Conatus Pharmaceuticals (CNAT) United States $0.144B 0.00
Chembio Diagnostics (CEMI) United States $0.137B 0.00
United-Guardian (UG) United States $0.080B 17.61
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.31
Imprimis Pharmaceuticals (IMMY) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.057B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00